MAPT and Parkinson disease: Combining pathologies in mice overexpressing fAD mutations in APP and PSEN1, FTDP-17 mutant MAPT, and PD associated SCNA, there is a synergistic effect of the pathological proteins resulting in exacerbated pathological and behavioral phenotypes [23].